Jefferies lowered the firm’s price target on Surgery Partners (SGRY) to $15 from $16.25 and keeps a Buy rating on the shares. The relative underperformance of healthcare services stocks highlights concerns among investors about Q1 volumes, notes the analyst, who is “unsure if Street numbers adequately reflect” drags from ice storms in Southern states and snow storms in the East Coast that impacted volumes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGRY:
- Ortelius says ‘it’s time for substantial change’ at Surgery Partners
- Surgery Partners price target lowered to $20 from $28 at TD Cowen
- Surgery Partners price target lowered to $17 from $19 at Mizuho
- Surgery Partners price target lowered to $21 from $29 at UBS
- Surgery Partners price target lowered to $24 from $30 at Benchmark